| 1 |
33967795 | CYP3A5 and UGT1A9 Polymorphisms Influence Immunosuppressive Therapy in Pediatric Kidney Transplant Recipients. | 2021 |
1 |
| 2 |
29550576 | Influence of CYP3A5 genetic differences in tacrolimus on quantitative interstitial fibrosis and long-term graft function in kidney transplant recipients. | 2018 May |
1 |
| 3 |
28611384 | The correlation between the expression of genes involved in drug metabolism and the blood level of tacrolimus in liver transplant receipts. | 2017 Jun 13 |
1 |
| 4 |
22469198 | Identification of factors affecting tacrolimus level and 5-year clinical outcome in kidney transplant patients. | 2012 Oct |
1 |
| 5 |
21544031 | Expression of CYP3A5 and P-glycoprotein in renal allografts with histological signs of calcineurin inhibitor nephrotoxicity. | 2011 May 27 |
1 |
| 6 |
18315786 | No pharmacokinetic interactions between mycophenolic acid and tacrolimus in renal transplant recipients. | 2008 Apr |
1 |
| 7 |
17048977 | Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients. | 2006 |
1 |